Cargando…

Application of artificial neural network model in diagnosis of Alzheimer’s disease

BACKGROUND: Alzheimer’s disease has become a public health crisis globally due to its increasing incidence. The purpose of this study was to establish an early warning model using artificial neural network (ANN) for early diagnosis of AD and to explore early sensitive markers for AD. METHODS: A popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Naibo, Chen, Jinghua, Xiao, Hui, Wu, Lei, Jiang, Han, Zhou, Yueping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613238/
https://www.ncbi.nlm.nih.gov/pubmed/31286894
http://dx.doi.org/10.1186/s12883-019-1377-4
_version_ 1783433014717448192
author Wang, Naibo
Chen, Jinghua
Xiao, Hui
Wu, Lei
Jiang, Han
Zhou, Yueping
author_facet Wang, Naibo
Chen, Jinghua
Xiao, Hui
Wu, Lei
Jiang, Han
Zhou, Yueping
author_sort Wang, Naibo
collection PubMed
description BACKGROUND: Alzheimer’s disease has become a public health crisis globally due to its increasing incidence. The purpose of this study was to establish an early warning model using artificial neural network (ANN) for early diagnosis of AD and to explore early sensitive markers for AD. METHODS: A population based nested case-control study design was used. 89 new AD cases with good compliance who were willing to provide urine and blood specimen were selected from the cohort of 2482 community-dwelling elderly aged 60 years and over from 2013 to 2016. For each case, two controls living nearby were identified. Biomarkers for AD in urine and blood, neuropsychological functions and epidemiological parameters were included to analyze potential risk factors of AD. Compared with logistic regression, k-Nearest Neighbor (kNN) and support vector machine (SVM) model, back-propagation neural network of three-layer topology structures was applied to develop the early warning model. The performance of all models were measured by sensitivity, specificity, accuracy, positive prognostic value (PPV), negative prognostic value (NPV), the area under curve (AUC), and were validated using bootstrap resampling. RESULTS: The average age of AD group was about 5 years older than the non-AD controls (P < 0.001). Patients with AD included a significantly larger proportion of subjects with family history of dementia, compared with non-AD group. After adjusting for age and gender, the concentrations of urinary AD7c-NTP and aluminum in blood were significantly higher in AD group than non-AD group (2.01 ± 1.06 vs 1.03 ± 0.43, 1.74 ± 0.62 vs 1.24 ± 0.41 respectively), but the concentration of Selenium in AD group (2.26 ± 0.59) was significantly lower than that in non-AD group (2.61 ± 1.07). All the models were established using 18 variables that were significantly different between AD patients and controls as independent variables. The ANN model outperformed the other classifiers. The AUC for this ANN was 0.897 and the model obtained the accuracy of 92.13%, the sensitivity of 87.28% and the specificity of 94.74% on the average. CONCLUSIONS: Increased risk of AD may be associated with higher age among senior citizens in urban communities. Urinary AD7c-NTP is clinically valuable for the early diagnosis. The established ANN model obtained a high accuracy and diagnostic efficiency, which could be a low-cost practicable tool for the screening and diagnosis of AD for citizens.
format Online
Article
Text
id pubmed-6613238
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66132382019-07-17 Application of artificial neural network model in diagnosis of Alzheimer’s disease Wang, Naibo Chen, Jinghua Xiao, Hui Wu, Lei Jiang, Han Zhou, Yueping BMC Neurol Research Article BACKGROUND: Alzheimer’s disease has become a public health crisis globally due to its increasing incidence. The purpose of this study was to establish an early warning model using artificial neural network (ANN) for early diagnosis of AD and to explore early sensitive markers for AD. METHODS: A population based nested case-control study design was used. 89 new AD cases with good compliance who were willing to provide urine and blood specimen were selected from the cohort of 2482 community-dwelling elderly aged 60 years and over from 2013 to 2016. For each case, two controls living nearby were identified. Biomarkers for AD in urine and blood, neuropsychological functions and epidemiological parameters were included to analyze potential risk factors of AD. Compared with logistic regression, k-Nearest Neighbor (kNN) and support vector machine (SVM) model, back-propagation neural network of three-layer topology structures was applied to develop the early warning model. The performance of all models were measured by sensitivity, specificity, accuracy, positive prognostic value (PPV), negative prognostic value (NPV), the area under curve (AUC), and were validated using bootstrap resampling. RESULTS: The average age of AD group was about 5 years older than the non-AD controls (P < 0.001). Patients with AD included a significantly larger proportion of subjects with family history of dementia, compared with non-AD group. After adjusting for age and gender, the concentrations of urinary AD7c-NTP and aluminum in blood were significantly higher in AD group than non-AD group (2.01 ± 1.06 vs 1.03 ± 0.43, 1.74 ± 0.62 vs 1.24 ± 0.41 respectively), but the concentration of Selenium in AD group (2.26 ± 0.59) was significantly lower than that in non-AD group (2.61 ± 1.07). All the models were established using 18 variables that were significantly different between AD patients and controls as independent variables. The ANN model outperformed the other classifiers. The AUC for this ANN was 0.897 and the model obtained the accuracy of 92.13%, the sensitivity of 87.28% and the specificity of 94.74% on the average. CONCLUSIONS: Increased risk of AD may be associated with higher age among senior citizens in urban communities. Urinary AD7c-NTP is clinically valuable for the early diagnosis. The established ANN model obtained a high accuracy and diagnostic efficiency, which could be a low-cost practicable tool for the screening and diagnosis of AD for citizens. BioMed Central 2019-07-08 /pmc/articles/PMC6613238/ /pubmed/31286894 http://dx.doi.org/10.1186/s12883-019-1377-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Naibo
Chen, Jinghua
Xiao, Hui
Wu, Lei
Jiang, Han
Zhou, Yueping
Application of artificial neural network model in diagnosis of Alzheimer’s disease
title Application of artificial neural network model in diagnosis of Alzheimer’s disease
title_full Application of artificial neural network model in diagnosis of Alzheimer’s disease
title_fullStr Application of artificial neural network model in diagnosis of Alzheimer’s disease
title_full_unstemmed Application of artificial neural network model in diagnosis of Alzheimer’s disease
title_short Application of artificial neural network model in diagnosis of Alzheimer’s disease
title_sort application of artificial neural network model in diagnosis of alzheimer’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613238/
https://www.ncbi.nlm.nih.gov/pubmed/31286894
http://dx.doi.org/10.1186/s12883-019-1377-4
work_keys_str_mv AT wangnaibo applicationofartificialneuralnetworkmodelindiagnosisofalzheimersdisease
AT chenjinghua applicationofartificialneuralnetworkmodelindiagnosisofalzheimersdisease
AT xiaohui applicationofartificialneuralnetworkmodelindiagnosisofalzheimersdisease
AT wulei applicationofartificialneuralnetworkmodelindiagnosisofalzheimersdisease
AT jianghan applicationofartificialneuralnetworkmodelindiagnosisofalzheimersdisease
AT zhouyueping applicationofartificialneuralnetworkmodelindiagnosisofalzheimersdisease